Real-world patterns of immunoglobulin replacement therapy for infection prevention in common variable immunodeficiency: a multicenter nationwide studyPedro Moral, Marta Dafne Cabañero-Navalón, Arnau Antolí et al.|Frontiers in Immunology|2025Cited by 5
Infectious outcomes of a standardized subcutaneous immunoglobulin dose reduction strategy in primary immune deficiencies amid global shortagePedro Moral, Víctor García-Bustos, Héctor Balastegui-Martín et al.|Frontiers in Immunology|2025Cited by 4
Patient-centered outcomes with subcutaneous immunoglobulin use for infection control in primary and secondary immunodeficiencies: data of a GEIE Spanish RegistrySandra Martínez Mercader, Marta Dafne Cabañero-Navalón, Pedro Moral et al.|Frontiers in Immunology|2025Cited by 4